andolast
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
KCNMA1 activator
Indication:Bronchial asthma, COPD, Allergic rhinitis
Chemistry & pharmacology
Loading structure…
SMILES
O=C(Nc1ccc(-c2nnn[nH]2)cc1)c1ccc(-c2nnn[nH]2)cc1- Mol. weight
- 333.32 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL119549 ↗
Also known as
- 4-(1h-tetrazol-5-yl)-n-(4-(1h-tetrazol-5-yl)phenyl)benzamide
- andolast
- andolast
- benzamide, 4-(1h-tetrazol-5-yl)-n-(4-(1h-tetrazol-5-yl)phenyl)-
- cr2039
- cr 2039
- cr-2039
- cr-2039
- cr-2039